# When galaxies burst II. Implications of enhanced burstiness for the 21-cm Cosmic Dawn signal

Preprint · Hovav Lazare, Sarah Libanore, Eleonora Vanzan, Julian B. Muñoz, Ely D. Kovetz

- Archive id: arxiv:2607.20651
- Published: 2026-07-22
- arXiv: https://arxiv.org/abs/2607.20651
- Source URL: https://arxiv.org/abs/2607.20651
- PDF: https://arxiv.org/pdf/2607.20651
- Provenance: arxiv

## Abstract

Recent JWST observations suggest that star formation in the early universe was substantially burstier than assumed in standard models. Such burstiness can be described as a stochastic process characterized by the burst amplitude and the coherence time of star formation epochs. In this paper, we investigate how bursty star formation modifies the 21-cm power spectrum during Cosmic Dawn through its impact on the non-local radiation fields that govern its evolution, namely Lyman-$α$ and X-ray backgrounds. To do so, we introduce an unequal-time correlation in the star-formation-rate density sourcing the two fields and we compute its impact using the analytical framework implemented in the public code Zeus21. We find that the burstiness-induced time correlation produces a shot-noise-like contribution in the Lyman-$α$ and X-ray fields, enhancing both their auto- and cross-power spectra while leaving the global 21-cm signal, $T\_{21}(z)$, unchanged. As a result, the 21-cm power spectrum is strongly modified by a shot-noise-like contribution at the beginning of the Cosmic Dawn, where the signal is dominated by lower-mass halos ($M\_h\\lesssim10^{10}\\,M\_\\odot$), and is boosted by a factor of a few near the Wouthuysen-Field absorption trough. Elsewhere at low redshift, where the clustering signal dominates and larger halos drive the signal, the burstiness component is negligible.

_Abstract reproduced under CC0-1.0 (arXiv descriptive metadata)._

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.